Please use this identifier to cite or link to this item:
Title: Design synthesis and preliminary evaluation of 2cyano pyrrolidine derivatives for their DPP4 inhibiting activity
Researcher: Parag Anilkumar Rabara
Guide(s): Nurudin P Jivani
Keywords: DPP-4 inhibitors, 2-cyano pyrrolidine, GLP-1
University: Gujarat Technological University
Completed Date: 16-10-2018
Abstract: The current therapeutic agents for Type 2 diabetes (like Insulin, Sulphonylureas, Biguanides, and#945;-Glucosidase inhibitors, PPAR agonist and GLP-1 agonist), although effective in increasing insulin secretion, are associated with some safety issue and undesirable side effects, including hypoglycemia, abnormalities in cardiovascular responses and and#946;-cell apoptosis. DPP-4 inhibitors offer several potential advantages over existing therapies including decreased risk of hypoglycemia, potential for weight loss, and the potential for regeneration and differentiation of pancreatic and#946;-cells. Moreover, DPP-4 inhibitors can also be administered orally. Among all DPP-4 inhibitor derivatives, 2-Cyano pyrrolidine-based inhibitors have been studied most extensively. Apart from behaving as a proline mimic, the presence of the nitrile on the five-membered ring was shown to provide (i) nanomolar inhibition of DPP-4 and (ii) chemical stability adequate for oral administration. Most widely explored 2-cyano pyrrolidine class of DPP-4 inhibitors contains cyano or nitrile function that binds with catalytic serine and forms an imidate to show slow tight-binding kinetics. But, same cyanopyrrolidines undergo intramolecular cyclization of the free amino group at P2 site onto the electrophilic cyano or nitrile group at P1 site and leads to the stability issue. Therefore, 1-(2-chloroacetyl) pyrrolidine-2-carbonitrile intermediate moiety was fused with different heterocyclic derivatives like 1,3,4-thiadiazoles, Benzothiazoles, Phenyl Thiazoles, 1,3,4-oxadiazoles and 3,4-dihydroquinazolins to get novel 2-cyanopyrrolidine derivatives. All synthesized DPP-4 inhibitor derivatives were screened by DPP-4 inhibitor screening assay method which employs fluorogenic substrate, Gly-Pro-Aminomethylcoumarin (AMC), to measure DPP-4 activity. DPP cleave the peptide bond and releases the free AMC group which results in fluorescence and it was analyzed using an excitation wavelength of 350-360 nm and emission wavelength of 450-465 nm. newline newline
Pagination: xxiv, 128
Appears in Departments:Pharmacy

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File104.47 kBAdobe PDFView/Open
02_declaration.pdf218.35 kBAdobe PDFView/Open
03_certificate.pdf1.35 MBAdobe PDFView/Open
04_abstract.pdf158.1 kBAdobe PDFView/Open
05_acknowledgement.pdf595.76 kBAdobe PDFView/Open
06_contents.pdf750.3 kBAdobe PDFView/Open
07_abbreviations.pdf156.65 kBAdobe PDFView/Open
08_symbols.pdf323.68 kBAdobe PDFView/Open
09_list_of_figures.pdf259.24 kBAdobe PDFView/Open
10_list_of_tables.pdf242.98 kBAdobe PDFView/Open
11_chapter 1.pdf1.52 MBAdobe PDFView/Open
12_chapter 2.pdf931.27 kBAdobe PDFView/Open
13_chapter 3.pdf645.35 kBAdobe PDFView/Open
14_chapter 4.pdf3.74 MBAdobe PDFView/Open
15_chapter 5.pdf81.02 kBAdobe PDFView/Open
16_references.pdf919.17 kBAdobe PDFView/Open

Items in Shodhganga are protected by copyright, with all rights reserved, unless otherwise indicated.